{
  "id": "materia-medica",
  "title": "Materia medica",
  "lang": "en",
  "source_lang": "en",
  "summary": "Materia medica encompasses medicinal substances and the accumulated knowledge describing their identities, preparation, properties, and uses across medical traditions.",
  "category": "health",
  "subcategory": "drugs",
  "type": "concept",
  "aliases": [
    "Medical materials",
    "Materia medica literature"
  ],
  "generated_at": "2026-11-06",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/materia-medica/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/materia-medica/",
      "json": "https://aiwiki.page/zh/materia-medica.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Materia medica is a Latin expression meaning “medical material” or “medicinal substance.” It denotes both the substances used in treatment and the organized knowledge describing their origins, identification, preparation, properties, and uses. Historically, it included plant, animal, and mineral materials, together with processed products and compound preparations. The term also designated a field of medical teaching and a substantial genre of reference literature.\n\nFor many centuries, materia medica connected medicine, natural history, commerce, and practical knowledge of the environment. Its texts recorded not only therapeutic claims but also names, geographical sources, distinguishing features, methods of collection, adulterants, and preparation techniques. Their contents therefore illuminate the histories of pharmacy, agriculture, scientific classification, and long-distance trade, as well as changing explanations of disease.\n\nFrom the nineteenth century onward, much of this broad field differentiated into pharmacology, pharmaceutical chemistry, pharmacognosy, and regulatory drug standards. Nevertheless, materia medica remains a useful historical category and an active term in several medical traditions. Its interpretation requires a distinction between documenting what a substance was believed to do, establishing what material a historical name actually denoted, and demonstrating its effects through modern investigation."
    },
    {
      "heading": "Meaning, scope, and literary forms",
      "text": "Materia medica has several related meanings that should not be treated as interchangeable. It may refer to a collection of medicinal materials, to knowledge about those materials, or to a book presenting that knowledge. A nineteenth-century university course bearing the title could cover drug sources, preparation, physiological effects, and therapeutic applications. A contemporary historical study may instead use the term for a particular community’s repertoire of remedies, including knowledge preserved through practice rather than writing.\n\nThe traditional scope was broader than herbal medicine. Roots, leaves, flowers, seeds, resins, and woods formed a large part of many collections, but animal fats, waxes, shells, insects, salts, metals, and mineral compounds also appeared. A medicinal “simple” was ordinarily a single ingredient, although it might itself be chemically complex. A compound medicine combined several ingredients according to a recipe. Both categories could involve substantial processing: drying, roasting, grinding, extraction, fermentation, or distillation might turn a raw material into a preparation regarded as therapeutically distinct.\n\nSeveral neighboring literary forms organized this information differently. An herbal concentrated primarily on plants and their identification and uses. An antidotary or formulary generally emphasized compound recipes, quantities, and preparation. A dispensatory explained medicines and their manufacture, often commenting on an official standard. A pharmacopoeia acquired a more specifically normative role: it prescribed recognized substances, preparations, or quality requirements within a jurisdiction or institution. Historical boundaries between these genres were porous, and a single volume might combine botanical descriptions, recipes, commercial information, and therapeutic discussion.\n\nMateria medica also differed from a general treatise on treatment. Therapeutics could begin with a disease or symptom and ask which intervention to use; a materia medica commonly began with a substance and listed its attributed actions and applications. Its arrangement might be alphabetical, botanical, geographical, or based on qualities and effects. This structure encouraged comparison among substitutes and helped practitioners navigate materials sold under multiple names. It also made the genre especially receptive to additions from newly encountered regions.\n\nThe same expression later acquired specialized meanings. In homeopathy, a materia medica records symptom descriptions associated with substances through the tradition’s “provings” and clinical literature. That genre should not be confused with experimental pharmacology or with evidence that a preparation treats a disease. Likewise, the modern historical category “materia medica” can be applied comparatively to different societies without implying that their concepts, institutions, or standards of proof were identical."
    },
    {
      "heading": "Ancient Mediterranean foundations",
      "text": "Written records of medicinal substances long predate the Latin expression. Mesopotamian medical tablets contain recipes using plant, mineral, and animal ingredients, while the Egyptian Ebers Papyrus, conventionally dated to about 1550 BCE, preserves extensive medical and pharmaceutical material. Such documents show that preparation, combination, and routes of administration were already important concerns. They do not, however, constitute an early version of a single continuous modern science: their medical reasoning belonged to particular linguistic, religious, and social settings.\n\nIn the Greek-speaking Mediterranean, the Hippocratic writings discussed foods, medicines, evacuation, and the effects of environmental conditions on health. Theophrastus, writing in the late fourth and early third centuries BCE, described plants, their habitats, and practical uses, including medicinal ones. These traditions linked treatment to broader natural knowledge, while distinguishing substances through observable features and reported effects. Information came from cultivation, collecting, commerce, and specialist occupations as well as from learned physicians.\n\nThe most influential ancient work in the genre was Pedanius Dioscorides’ De materia medica, composed in Greek in the first century CE. Organized into five books, it described roughly 600 plants as well as numerous animal and mineral materials. Its entries could include names, appearance, habitat, preparation, storage, adulteration, and therapeutic uses. The work was practical rather than a systematic botanical classification in the modern sense. Its authority persisted through manuscript copying, translation, commentary, and adaptation for more than a millennium.\n\nGalen, active in the second century CE, provided another major framework. His writings on simple and compound medicines connected their effects to qualities such as heating, cooling, drying, and moistening. Within humoral theory, treatment was often interpreted as counteracting an imbalance or an excessive quality. Degrees of medicinal action helped practitioners compare substances and explain why some were stronger than others. These concepts organized reasoning about remedies even when the substances concerned had effects now explained through different mechanisms.\n\nSurvival depended on material transmission. The richly illustrated Vienna Dioscurides, produced around 512 CE for the Byzantine aristocrat Juliana Anicia, is a prominent example of a manuscript adapting ancient pharmaceutical knowledge for a later setting. Images, labels, and textual arrangements could assist identification, but copying also introduced altered spellings, displaced illustrations, and uncertain equivalences. A name in an ancient text therefore cannot automatically be matched to one modern species. Geography, description, associated names, and the history of manuscript transmission all matter when reconstructing what an author meant."
    },
    {
      "heading": "Arabic-language scholarship and medieval exchange",
      "text": "From the eighth century onward, translation into Arabic brought Greek medical and philosophical writings into new scholarly settings. Dioscorides and Galen became important authorities, but Arabic-language materia medica was not simply a repository of translated Greek texts. Scholars, physicians, pharmacists, merchants, and travelers compared inherited descriptions with materials available across the Mediterranean, western and central Asia, and the Indian Ocean. Their work incorporated substances and terminology from Persian, Indian, and other traditions.\n\nTranslation itself created practical problems. A Greek plant name might have no familiar Arabic equivalent, while the same traded substance could circulate under several names. An apparently straightforward lexical substitution could therefore conceal a different species, a substitute, or an imported product whose source remained uncertain. Commentators supplied synonyms, local names, descriptions, and judgments about authenticity. This work was a form of technical investigation: identifying the referent of a word could determine which material entered a preparation.\n\nIbn Sina, known in Latin as Avicenna, assembled a major account of medicine in the Canon of Medicine during the early eleventh century. Its second book treated simple drugs, while the fifth addressed compound medicines. The work discussed qualities, actions, and principles for assessing medicinal effects within its inherited medical framework. Its subsequent Latin translation helped make it a central text in European university medicine. Its historical importance lies in this organization and transmission of knowledge, not in treating all its therapeutic claims as established by current standards.\n\nIbn al-Baytar, who died in 1248, compiled an extensive work on simple medicines and foods, commonly known as the Comprehensive Book on Simple Drugs and Foodstuffs. It contains approximately 1,400 entries and combines citations from earlier authors with observations and information gathered through travel. Such compilations preserved disagreements as well as agreements. Differences in names, habitat, strength, and preparation could be made visible rather than compressed into a single unqualified assertion.\n\nPharmaceutical practice also developed through hospitals, markets, and specialized preparation manuals. Al-Kindi’s ninth-century formulary and Sabur ibn Sahl’s Aqrabadhin illustrate the importance of compound recipes and reproducible procedures. In Latin Europe, translations produced in places such as Toledo and southern Italy brought Arabic medical literature into teaching and practice. Works associated with the Salernitan tradition, including the Circa instans, described medicinal simples and their handling. The resulting traditions were connected but not uniform: local availability, institutional authority, and commercial supply shaped which remedies were actually used."
    },
    {
      "heading": "South Asian and East Asian traditions",
      "text": "South Asian medical literature developed extensive accounts of medicinal substances within Ayurveda. The Caraka Samhita and Sushruta Samhita, texts formed through complex processes of composition and revision, discuss ingredients, preparations, and therapeutic applications alongside broader accounts of the body and disease. The category dravya concerns substances, while dravyaguna addresses their properties and actions. Interpretive categories include taste, qualities, potency, and effects after digestion. These are elements of a particular medical system rather than alternative names for modern chemical or physiological measurements.\n\nLater Sanskrit nighantus, or specialized lexicons, organized names, synonyms, properties, and uses of medicinal materials. Such works were important because a substance could have different names across regions and languages, while one name might be applied to more than one material. South Asian pharmaceutical traditions also included elaborate processing and mineral preparations. Historical claims that processing transformed a substance’s properties have to be distinguished from modern analytical findings about its composition, exposure, and toxicity; the historical description alone establishes neither safety nor efficacy.\n\nIn China, bencao, conventionally translated as “materia medica,” became a major textual tradition. The Shennong bencao jing, generally associated with the early centuries CE in its compiled form, traditionally lists 365 substances divided into three grades. Its attribution to the culture hero Shennong is not an identification of a historical author. Later scholars revised classifications, added commentary, compared names and sources, and distinguished substances available in different regions. Chinese materia medica thus developed through repeated editorial and practical reworking.\n\nThe state-sponsored Xinxiu bencao, completed in 659 under the Tang dynasty, combined textual revision with an officially organized effort to describe medicinal materials. Li Shizhen’s Bencao gangmu, first printed in 1596, brought together approximately 1,900 substances in a much larger classificatory and historical synthesis. Its entries discuss names, sources, processing, attributed properties, and earlier opinions. It is valuable not only for the remedies it records but also for the way it evaluates textual inheritance and tries to resolve contradictory identifications.\n\nWithin traditional Chinese medicine, substances are commonly described through categories including temperature characteristics, flavors, and associations with functional systems. These should be presented as traditional explanatory categories, not equated directly with anatomical organs or molecular mechanisms. Processing, known as paozhi, can alter the material used: steaming, heating, or treatment with other ingredients may change chemical composition as well as appearance. Consequently, a reference to a plant species alone may be insufficient to identify the medicinal product described in a historical source.\n\nChinese texts and practices circulated to Korea, Japan, and elsewhere, where they were adapted to local environments and institutions. Other Asian traditions, including Tibetan medicine and Unani medicine, developed their own materia medica through regional exchange and distinct systems of classification. These histories do not fit a single line of descent from one foundational book. They involve translation, substitution, ecological knowledge, state patronage, and interaction among medical communities across many centuries."
    },
    {
      "heading": "Printing, overseas expansion, and the early modern drug trade",
      "text": "The expansion of printing changed the scale and organization of materia medica in Europe. Printed books could circulate in larger numbers than manuscripts and allow readers in different places to consult more nearly identical editions. Yet print did not automatically eliminate error: an incorrect identification or illustration could also be reproduced widely. Editors compared manuscripts, revisited ancient languages, and added observations, while printers and illustrators helped shape which features readers could recognize.\n\nSixteenth-century herbals increasingly emphasized recognizable depictions of plants. Otto Brunfels’ Herbarum vivae eicones, published from 1530, and Leonhart Fuchs’ De historia stirpium of 1542 are important examples. Images based on observed specimens strengthened the relationship between medicinal writing and botanical investigation. Nevertheless, a carefully drawn plant did not settle every question. The drawing might show a European species proposed as the equivalent of an ancient drug, while the historical identification remained uncertain.\n\nOceanic commerce enlarged the European materia medica and reorganized existing supply networks. Garcia de Orta’s Colloquies on the Simples and Drugs of India, printed at Goa in 1563, discussed Asian medicinal commodities and challenged some inherited accounts through local inquiry. Nicolás Monardes wrote about products arriving from the Americas, often investigating them in Seville rather than at their places of origin. These works demonstrate different forms of access to knowledge: residence in a trading center, consultation with local experts, examination of imported samples, and compilation from reports.\n\nCinchona bark provides a particularly revealing case. Introduced into European medicine from the Andes during the seventeenth century, it became an important treatment for intermittent fevers, including malaria. Its movement depended on Indigenous knowledge, colonial institutions, merchants, collectors, and changing medical interpretations. Different bark sources varied in composition, and commercial names did not always correspond reliably to botanical species. The later isolation of quinine did not erase these earlier problems of sourcing and identification; it made some of them experimentally measurable.\n\nGlobal exchange also created opportunities for appropriation and unequal recognition. Printed authors and colonial institutions often received durable credit, while the contributions of collectors, healers, cultivators, translators, and enslaved or otherwise coerced workers were less fully recorded. Historical analysis therefore examines not only what entered a European book but also how information and specimens were obtained. A commercial label or published description may preserve only a small part of the knowledge and labor behind a medicine.\n\nOfficial standards grew within this changing market. The Florentine Nuovo receptario of 1498 and the Pharmacopoeia Londinensis of 1618 illustrate efforts to regularize preparations and ingredients. Such publications helped define professional obligations and recognized formulas, but implementation depended on inspection, training, supply, and local practice. Standardization was an institutional process rather than a single achievement secured by publication."
    },
    {
      "heading": "Identifying, preparing, and standardizing medicinal materials",
      "text": "Identification is a foundational problem because a medicinal name is not necessarily a biological identity. A vernacular name may denote different species in different places, while a single species can have many names. Historical categories may also group materials by appearance, taste, origin, or supposed function rather than evolutionary relationship. Modern botanical nomenclature provides a more explicit naming system, but translating older terminology into it requires evidence rather than resemblance alone.\n\nA complete identification may need the species, plant part, developmental stage, geographical origin, and processing history. Bark and leaves from the same plant can have different compositions, and a root harvested at one stage may differ from material collected later. A herbarium voucher preserves a documented specimen against which a botanical identification can be checked. In commercial materials that are powdered, extracted, or extensively processed, the diagnostic structures needed for ordinary identification may no longer be visible.\n\nTraditional examination relied heavily on sensory and physical characteristics: color, odor, texture, fracture, taste, and the appearance of a cut surface. Microscopy later made it possible to recognize cell types, hairs, starch grains, vessels, and other diagnostic features in fragmented material. Chemical testing added another level. Chromatography can separate constituents and generate characteristic profiles, while mass spectrometry and spectroscopy help characterize molecules. DNA sequencing can assist species identification, although processing may degrade DNA and genetic identity alone does not establish chemical strength or purity.\n\nPreparation also affects what is delivered. Water infusions, decoctions, alcoholic tinctures, oils, and dry powders extract or retain different components. Extraction depends on solvent, temperature, time, particle size, and the chemistry of the constituents. A historical statement about one preparation cannot therefore be transferred automatically to another. Even when both originate from the same species, a concentrated extract and a traditional water preparation may differ substantially in composition and exposure.\n\nStandardization can address several different properties. An identity standard establishes what a material is; a purity standard limits contaminants or unwanted material; an assay measures a specified constituent or biological activity. A chemical marker may be useful for quality control without being the main contributor to therapeutic action. Conversely, a complex mixture may contain several active and inactive constituents whose proportions vary. Uniformity in one measured marker does not necessarily make every relevant property uniform.\n\nAdulteration and substitution must likewise be distinguished. An openly declared substitute used because the original material is unavailable is not the same as concealed replacement for commercial gain. Either can change a preparation’s properties, but their historical interpretation differs. Modern quality control may examine microbial contamination, pesticide residues, toxic elements, and undeclared pharmaceutical ingredients in addition to botanical identity. These tests continue an old concern of materia medica—whether the material supplied is what its name claims—using more specific analytical methods."
    },
    {
      "heading": "From materia medica to experimental pharmacology",
      "text": "During the eighteenth and nineteenth centuries, the broad subject of materia medica increasingly divided into specialized sciences. Botanical investigation clarified sources; chemistry separated and characterized constituents; physiology studied effects on living systems; and pharmaceutical institutions developed manufacturing and analytical standards. The change was gradual and geographically uneven. Textbooks continued to use “materia medica” even as their contents became more chemical and experimental.\n\nWilliam Withering’s An Account of the Foxglove of 1785 illustrates an important transitional form. Withering described the use of foxglove in patients with dropsy, a historical category involving fluid accumulation rather than one uniform modern diagnosis. He recorded observations about effects, toxicity, and circumstances of use. His work did not employ contemporary randomized trial methods, but it attempted to distinguish useful observations from indiscriminate claims. Later research connected digitalis constituents with specific cardiac actions and with the need for careful control of exposure.\n\nIsolation of active compounds changed what counted as a medicinal object. Friedrich Sertürner’s early nineteenth-century work on opium led to the isolation and characterization of morphine. In 1820, Pierre-Joseph Pelletier and Joseph-Bienaimé Caventou isolated quinine from cinchona bark. A named plant product could now be studied alongside a purified constituent, allowing more reproducible dosing and more direct investigation of chemical structure and biological action. Isolation did not guarantee safety, but it made important sources of variation easier to define.\n\nExperimental pharmacology acquired institutional form during the nineteenth century. Rudolf Buchheim established an experimental pharmacology laboratory at Dorpat in the 1840s, and Oswald Schmiedeberg later helped develop the discipline at Strasbourg. Their approach emphasized systematic investigation of drug actions rather than reliance on accumulated therapeutic descriptions alone. Pharmacodynamics came to address what drugs do to biological systems, while pharmacokinetics describes processes governing drug absorption, distribution, metabolism, and elimination.\n\nThis transformation also changed classification. Older texts might group medicines as astringents, purgatives, stimulants, or substances with heating and cooling qualities. Modern classifications could instead distinguish chemical families, molecular targets, physiological effects, or clinical indications. These systems overlap only partly. One traditional category may include substances with several mechanisms, while one molecular mechanism may produce different clinical effects depending on dose, tissue, and route of administration.\n\nPharmacognosy retained a particular focus on medicines from natural sources, including their identity, constituents, biosynthesis, and quality. Meanwhile, industrial synthesis, microbial fermentation, and biotechnology expanded the range of medicines beyond the materials emphasized in older compendia. Contemporary drug development can still begin with a traditional use or a natural product, but it may also originate in target-based screening, chemical design, or biological engineering. Historical materia medica is therefore one source of leads and questions, not a complete predecessor that already contained modern pharmacological knowledge."
    },
    {
      "heading": "Therapeutic claims, clinical evidence, and safety",
      "text": "A materia medica entry can contain several kinds of statement: that a substance was used for a condition, that an author believed it effective, that it produces an observable physiological effect, or that it improves a defined clinical outcome. These statements require different evidence. Documentation of historical use establishes a practice and its cultural context; it does not by itself establish a favorable balance of benefit and harm. Likewise, demonstrating activity in a laboratory assay is not equivalent to demonstrating clinical effectiveness.\n\nModern evaluation links the identity of an intervention to a defined question. The species or chemical substance, preparation, dose, route, treatment duration, population, and outcome all affect interpretation. A clinical trial of one standardized extract cannot automatically establish the effects of every product bearing the same plant name. Where feasible and appropriate, a randomized controlled trial can reduce systematic differences between comparison groups. Blinding and suitable controls help distinguish an intervention’s effects from expectations, co-interventions, and differences in outcome assessment.\n\nHistorical disease terms create additional difficulties. “Dropsy,” “ague,” “melancholy,” or an expression translated as a traditional disease category may encompass conditions now separated by cause or mechanism. Retrospective identification can sometimes be plausible, but it requires contextual evidence and may remain uncertain. A claim that a remedy treated a historical category cannot simply be converted into a claim about a modern disease sharing one symptom. This matters when interpreting old reports of fever, swelling, pain, or digestive disturbance.\n\nSafety is also preparation-specific and exposure-dependent. Natural origin does not remove the possibility of toxicity, contamination, or interaction with other medicines. Aristolochic acids, present in certain Aristolochia species and related materials, are associated with severe kidney injury and urothelial cancer. Other risks arise from mistaken identity or product composition rather than from the intended ingredient. Modern pharmacovigilance uses reports and other data to investigate harms that may not be apparent in small studies or traditional accounts.\n\nInteractions can occur through several mechanisms. Constituents may alter drug-metabolizing enzymes or transport proteins, change absorption, or reinforce a physiological action such as sedation or inhibition of blood coagulation. St John’s wort provides a well-established example of a botanical product capable of reducing exposure to various medicines through enzyme and transporter induction. The importance of an interaction depends on the preparation and the medicine involved; naming an herb without specifying the product can conceal relevant variation.\n\nRegulatory systems distinguish quality standards, authorization, labeling, and evidence of therapeutic effect in different ways. A pharmacopoeial monograph ordinarily specifies identity and quality requirements; its existence is not itself proof that every claimed use has been clinically demonstrated. The World Health Organization has published medicinal-plant monographs and quality-control guidance, while national authorities operate under their own legal frameworks. Within evidence-based medicine, historical knowledge can inform questions, but clinical claims remain subject to evaluation of the relevant evidence."
    },
    {
      "heading": "Historical collections, digital scholarship, and biological resources",
      "text": "Materia medica survives in more than books. Dried drugs, teaching cabinets, apothecary jars, trade samples, illustrations, account books, and correspondence preserve evidence about how medicinal knowledge operated. A labeled specimen may connect a printed name to an actual traded material; a merchant’s ledger may reveal origin, price, substitution, or interrupted supply. Collections in universities, botanical gardens, pharmacies, and museums therefore provide evidence that cannot always be recovered from textual descriptions alone.\n\nTheir interpretation requires attention to provenance and change over time. A nineteenth-century jar may have been refilled, relabeled, or reorganized, and an old collection name may not match its present contents. Chemical degradation, insect damage, and conservation treatments can complicate analysis. Historians and scientists may combine archival research, microscopy, chemical characterization, and species identification, but each method answers a different question. Identifying today’s contents does not automatically establish what was present when the container first entered a collection.\n\nDigitization has made widely dispersed manuscripts and printed editions more accessible. Searchable transcriptions, image repositories, and databases of historical names can support comparison across languages and centuries. Yet optical character recognition performs unevenly on early typefaces, handwritten additions, and non-Latin scripts. Automatic matching is especially difficult when one historical name has several possible modern referents. A useful digital record therefore distinguishes the wording of a source, an editor’s proposed identification, the evidence supporting it, and the degree of certainty.\n\nEthnobotany and related fields examine relationships between communities and plants, including medicinal knowledge. Research may document preparation, collection practices, local classification, and changes caused by markets or environmental conditions. Such documentation raises questions about consent, attribution, access, and control over knowledge. Publication can preserve information, but it can also make knowledge available for uses its holders did not anticipate. Historical patterns of unequal recognition remain relevant to the governance of contemporary collections and databases.\n\nThe international legal setting includes the Convention on Biological Diversity and the Nagoya Protocol, adopted in 2010 and entering into force in 2014. The protocol establishes a framework for access to genetic resources and fair and equitable sharing of benefits arising from their utilization, including provisions concerning associated traditional knowledge within its scope. Its application depends on the resources, activities, jurisdictions, and domestic measures involved. It does not create a simple universal ownership rule for every historical recipe or published medicinal reference.\n\nConservation introduces a further material dimension. Wild collection, habitat loss, and demand can place pressure on medicinal species, while cultivation may alter supply and chemical variability. Trade in listed species may also be governed by international conservation controls. Research on historical materia medica can help trace changing sources and substitutions, but old descriptions of abundance cannot serve as present-day ecological assessments. Species-level identification, documented collection locality, lawful access, and reproducible preparation remain essential information when a historical medicinal material becomes the subject of contemporary scientific investigation."
    }
  ],
  "links": [
    "medicine",
    "pharmacy",
    "trade",
    "pharmacology",
    "chinese-materia-medica",
    "bencao-gangmu",
    "traditional-chinese-medicine",
    "printing",
    "malaria",
    "chromatography",
    "mass-spectrometry",
    "spectroscopy",
    "dna-sequencing",
    "diagnosis",
    "morphine",
    "pharmacodynamics",
    "pharmacokinetics",
    "drug-development",
    "clinical-trial",
    "randomized-controlled-trial",
    "blinding-clinical-trials",
    "pain",
    "pharmacovigilance",
    "enzyme",
    "world-health-organization",
    "evidence-based-medicine",
    "nagoya-protocol"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}